Arvee Laboratories (India) Ltd (NSE: ARVEE) is a Ahmedabad, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹249 Cr, it ranks #2,477 by market cap among the 6,137 Indian listed companies on FinBizNet, and #9 of 13 in Custom Synthesis and Specialty CDMO. At ₹189.07 (as of 25 Oct 2026), the share price is 35.0% below its 52-week high of ₹290.78 and 46.4% above its 52-week low of ₹129.11. The share price is up 17.6% over one year and up 23.0% over three months.
| Current Price | ₹189.07 |
|---|---|
| Market Cap | ₹249 Cr |
| NSE Symbol | ARVEE |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 93.9 |
| Return on Equity | 7.78% |
| Return on Assets | 3.07% |
| 52-Week Range | ₹129.11 – ₹290.78 |
| 1-Year Price Change | +17.6% |
| 3-Month Price Change | +23.0% |
| Beta (1Y) | 0.06 |
| Headquarters | Ahmedabad, Gujarat |
| Website | arveelabs.com |
| Revenue | ₹17 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 9.8% |
| EPS (Basic) | ₹1.54 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
1. Chemicals-This segment manufactures and sells various chemicals and pharmaceutical intermediates.
1. Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,389 Cr | 73.6 | 5.76% | ₹655 Cr | -2.2% |
| Neogen Chemicals Limited (Neogen) | ₹7,465 Cr | 227.6 | 3.58% | ₹250 Cr | +45.2% |
| Laxmi Organic Industries Ltd | ₹4,963 Cr | 59.9 | 4.08% | ₹968 Cr | -27.6% |
| Tatva Chintan Pharma Chem Ltd | ₹4,547 Cr | 105.8 | 5.53% | ₹217 Cr | +22.0% |
| Prasol Chemicals Limited | ₹4,476 Cr | 50.7 | — | ₹434 Cr | — |
| Paushak Ltd. | ₹2,046 Cr | 42.9 | 8.22% | ₹84 Cr | — |
| Sunshield Chemicals Ltd. | ₹906 Cr | 27.7 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹803 Cr | 33.4 | 4.80% | ₹65 Cr | -27.6% |
| Arvee Laboratories (India) Ltd | ₹249 Cr | 93.9 | 7.78% | ₹17 Cr | +17.6% |
Listed by market capitalisation. Ratios are shown for context only.
Arvee Laboratories (India) Ltd is trading at ₹189.07, with a market capitalisation of ₹249 Cr.
Arvee Laboratories (India) Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Arvee Laboratories (India) Ltd has a P/E of 93.9 and a return on equity of 7.78%.
Arvee Laboratories (India) Ltd is listed on the NSE under the symbol ARVEE.
Arvee Laboratories (India) Ltd's share price is up 17.6% over one year and up 23.0% over three months. Its 52-week range is ₹129.11 to ₹290.78.
In Q1 FY27, Arvee Laboratories (India) Ltd reported revenue of ₹17 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.54 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.